Damarys Rabelo
Family · Pembroke Pines, FLNPI 1427564483
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 202 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 26 manufacturers reported payments, led by Novo Nordisk at 32.5% of the total. Reporting peaked in 2021 at $2,510 and has fallen 99.2% since, to $20 in 2024. Among family clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 202 payments — averaging $19.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$1K
- AbbVie$508
- AstraZeneca$444
- GSK$284
- Boehringer Ingelheim$224
- Lilly USA, LLC$189
- plus $1K from 20 others
What the payments were for
- Food & beverage$3,952100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 75 | $1,284 |
| AbbVie | 33 | $508 |
| AstraZeneca | 13 | $444 |
| GSK | 8 | $284 |
| Boehringer Ingelheim | 9 | $224 |
| Lilly USA, LLC | 12 | $189 |
| Johnson & Johnson | 8 | $136 |
| Phadia US Inc. | 3 | $115 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 5 | $93 |
| Pfizer | 3 | $83 |
| Bayer | 3 | $71 |
| Merck | 3 | $59 |
| Currax Pharmaceuticals LLC | 4 | $59 |
| Esperion Therapeutics, Inc. | 2 | $54 |
| Abbott | 3 | $51 |
| Arbor Pharmaceuticals, Inc. | 3 | $43 |
| Biohaven Pharmaceuticals, Inc. | 2 | $41 |
| Eisai Inc. | 2 | $41 |
| Amgen | 2 | $32 |
| Jazz Pharmaceuticals Inc. | 2 | $29 |
| E.r. Squibb & Sons, L.L.C. | 2 | $28 |
| Idorsia Pharmaceuticals US Inc | 1 | $21 |
| Amarin Pharma, Inc. | 1 | $21 |
| Supernus Pharmaceuticals, Inc. | 1 | $19 |
| Vivus LLC | 1 | $12 |
| Corcept Therapeutics | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- UBRELVY$130
- BREZTRI$125
- TRELEGY ELLIPTA$122
- Wegovy$120
- Ozempic$118
How this compares
$3,952 in reported general payments places this provider in the 90th percentile of 14,618 family providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Albuterol Sulfate HfaAlbuterol Sulfate | 20 | $563 |
| Azithromycin | 23 | $249 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 19 | $227 |
| Prednisone | 16 | $19 |
Paid to pharmacies, not to this prescriber.
Other family in Pembroke Pines
- Lewis HarringtonTampa$954K
- Danielle PharesFt Lauderdale$713K
- Donna OrtizOrlando$417K
- Patrick SzarazMiami$327K
- Deena RodneyMaitland$323K
- Yamila MelendezMiami$212K
- Holly BoydLand O Lakes$200K
- Rachael BuschLoxahatchee$189K
- Victor Tatis de la NuezMiramar$161K
- Ronda CrewsJax Bch$155K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.